Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

Synthesis and biological activities of artemisinin-piperazine-dithiocarbamate derivatives.

Yu JY, Li XQ, Wei MX.

Eur J Med Chem. 2019 May 1;169:21-28. doi: 10.1016/j.ejmech.2019.02.071. Epub 2019 Mar 2.

PMID:
30852384
2.

Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo.

Cao Y, Feng YH, Gao LW, Li XY, Jin QX, Wang YY, Xu YY, Jin F, Lu SL, Wei MJ.

Int Immunopharmacol. 2019 May;70:110-116. doi: 10.1016/j.intimp.2019.01.041. Epub 2019 Feb 21.

3.

Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2).

von Hagens C, Walter-Sack I, Goeckenjan M, Storch-Hagenlocher B, Sertel S, Elsässer M, Remppis BA, Munzinger J, Edler L, Efferth T, Schneeweiss A, Strowitzki T.

Phytomedicine. 2019 Feb 15;54:140-148. doi: 10.1016/j.phymed.2018.09.178. Epub 2018 Sep 17.

PMID:
30668363
4.

Biotin-functionalized copolymeric PEG-PCL micelles for in vivo tumour-targeted delivery of artemisinin.

Nosrati H, Barzegari P, Danafar H, Kheiri Manjili H.

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):104-114. doi: 10.1080/21691401.2018.1543199.

PMID:
30663422
5.

The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells.

Greenshields AL, Fernando W, Hoskin DW.

Exp Mol Pathol. 2019 Apr;107:10-22. doi: 10.1016/j.yexmp.2019.01.006. Epub 2019 Jan 17.

PMID:
30660598
6.

Artemisinin inhibits breast cancer-induced osteolysis by inhibiting osteoclast formation and breast cancer cell proliferation.

Li J, Feng W, Lu H, Wei Y, Ma S, Wei L, Liu Q, Zhao J, Wei Q, Yao J.

J Cell Physiol. 2018 Dec 7. doi: 10.1002/jcp.27875. [Epub ahead of print]

PMID:
30536376
7.

Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer.

Yao Y, Guo Q, Cao Y, Qiu Y, Tan R, Yu Z, Zhou Y, Lu N.

J Exp Clin Cancer Res. 2018 Nov 26;37(1):282. doi: 10.1186/s13046-018-0960-7.

8.

Potential of bacterial culture media in biofabrication of metal nanoparticles and the therapeutic potential of the as-synthesized nanoparticles in conjunction with artemisinin against MDA-MB-231 breast cancer cells.

Khan BF, Hamidullah, Dwivedi S, Konwar R, Zubair S, Owais M.

J Cell Physiol. 2019 May;234(5):6951-6964. doi: 10.1002/jcp.27438. Epub 2018 Nov 15.

PMID:
30443899
9.

Synthesis of Artemisinin-Estrogen Hybrids Highly Active against HCMV, P. falciparum, and Cervical and Breast Cancer.

Fröhlich T, Kiss A, Wölfling J, Mernyák E, Kulmány ÁE, Minorics R, Zupkó I, Leidenberger M, Friedrich O, Kappes B, Hahn F, Marschall M, Schneider G, Tsogoeva SB.

ACS Med Chem Lett. 2018 Oct 19;9(11):1128-1133. doi: 10.1021/acsmedchemlett.8b00381. eCollection 2018 Nov 8.

PMID:
30429957
10.

[Design, synthesis and antiproliferative activity in cancer cells of novel dihydropyrazolyl and pyrazolyl artemisinin-phenyl ethers].

Wei YF, Huang M, Li AH, Zhao F, Zhong H, Liu D, Zhao LX.

Zhongguo Zhong Yao Za Zhi. 2018 Sep;43(17):3582-3588. doi: 10.19540/j.cnki.cjcmm.20180613.002. Chinese.

PMID:
30347929
11.

Towards rational design of RAD51-targeting prodrugs: platinumIV-artesunate conjugates with enhanced cytotoxicity against BRCA-proficient ovarian and breast cancer cells.

Zhang S, Yuan H, Guo Y, Wang K, Wang X, Guo Z.

Chem Commun (Camb). 2018 Oct 16;54(83):11717-11720. doi: 10.1039/c8cc06576d.

PMID:
30229259
12.

Artemisinin-Daumone Hybrid Inhibits Cancer Cell-Mediated Osteolysis by Targeting Cancer Cells and Osteoclasts.

Ma GT, Lee SK, Park KK, Park J, Son SH, Jung M, Chung WY.

Cell Physiol Biochem. 2018;49(4):1460-1475. doi: 10.1159/000493449. Epub 2018 Sep 11.

13.

L-A03, a dihydroartemisinin derivative, promotes apoptotic cell death of human breast cancer MCF-7 cells by targeting c-Jun N-terminal kinase.

Yao GD, Ge MY, Li DQ, Chen L, Hayashi T, Tashiro SI, Onodera S, Guo C, Song SJ, Ikejima T.

Biomed Pharmacother. 2018 Sep;105:320-325. doi: 10.1016/j.biopha.2018.05.093. Epub 2018 Jun 1.

PMID:
29864620
14.

Induction of Apoptosis in Human Breast Cancer MCF-7 Cells by a Semi-Synthetic Derivative of Artemisinin: A Caspase-Related Mechanism.

Jamalzadeh L, Ghafoori H, Aghamaali M, Sariri R.

Iran J Biotechnol. 2017 Sep 27;15(3):157-165. doi: 10.15171/ijb.1567. eCollection 2017.

15.

Artesunate promotes G2/M cell cycle arrest in MCF7 breast cancer cells through ATM activation.

Wen L, Liu L, Wen L, Yu T, Wei F.

Breast Cancer. 2018 Nov;25(6):681-686. doi: 10.1007/s12282-018-0873-5. Epub 2018 May 24.

PMID:
29797234
16.

Design, synthesis and biological evaluation of artemisinin derivatives containing fluorine atoms as anticancer agents.

Li S, Li G, Yang X, Meng Q, Yuan S, He Y, Sun D.

Bioorg Med Chem Lett. 2018 Jul 15;28(13):2275-2278. doi: 10.1016/j.bmcl.2018.05.035. Epub 2018 May 17.

PMID:
29789258
17.

Use of artesunate in non-malarial indications.

Raffetin A, Bruneel F, Roussel C, Thellier M, Buffet P, Caumes E, Jauréguiberry S.

Med Mal Infect. 2018 Jun;48(4):238-249. doi: 10.1016/j.medmal.2018.01.004. Epub 2018 Feb 13. Review.

PMID:
29422423
18.

Transcriptome analysis of genes associated with breast cancer cell motility in response to Artemisinin treatment.

Kumari K, Keshari S, Sengupta D, Sabat SC, Mishra SK.

BMC Cancer. 2017 Dec 15;17(1):858. doi: 10.1186/s12885-017-3863-7.

19.

Activities of 11-Azaartemisinin and N-Sulfonyl Derivatives against Neospora caninum and Comparative Cytotoxicities.

Harmse R, Wong HN, Smit FJ, Müller J, Hemphill A, N'Da DD, Haynes RK.

ChemMedChem. 2017 Dec 19;12(24):2094-2098. doi: 10.1002/cmdc.201700600. Epub 2017 Dec 6.

PMID:
29210523
20.

Synthesis, anticancer evaluation and pharmacokinetic study of novel 10-O-phenyl ethers of dihydroartemisinin.

Luan S, Zhong H, Zhao X, Yang J, Jing Y, Liu D, Zhao L.

Eur J Med Chem. 2017 Dec 1;141:584-595. doi: 10.1016/j.ejmech.2017.10.023. Epub 2017 Oct 10.

PMID:
29102180

Supplemental Content

Loading ...
Support Center